Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions.
Journal Information
Full Title: Mol Ther Methods Clin Dev
Abbreviation: Mol Ther Methods Clin Dev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of interests J.W. is an Independent Director on the Board of Atsena Therapeutics, Inc., and sits on the Board of Directors at ASGCT. R.R. has consulting agreements with and receives honoraria from Pfizer Inc., sits on ASGCT’s Board of Directors, receives research funding from Tessa Therapeutics, and receives honoraria from Kite-Gilead Sciences. The content of this article represents the authors’ opinions and may not necessarily represent the views of their employers."
"ASGCT; Ultragenyx Pharmaceuticals; ASGCT"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025